Publication date: Apr 15, 2025

We are delighted to share with you our latest recording “A new Parkinson’s test- hope or hype?” a webinar on the alpha-synuclein seed amplification assay (αSyn-SAA), presented by the M J Fox Foundation as a significant breakthrough in the search for a Parkinson’s biomarker. With the growing interest surrounding αSyn-SAA, it’s crucial for patients and their families to understand both its potential benefits and limitations. About the Speaker:-Dr. Alberto Espay is Professor and Endowed Chair of the James and Joan Gardner Center for Parkinson’s Disease at the University of Cincinnati. He has published over 300 research articles and 8 books, including Common Movement Disorders Pitfalls, which received the Highly Commended BMA Medical Book Award in 2013 and Brain Fables, the Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer them, co-authored with Parkinson’s patient and advocate Benjamin Stecher, selected by the Association of American Publishers for the PROSE Award honouring the best scholarly work in Neuroscience published in 2020. With colleagues at the University of Cincinnati, he recently launched the first biomarker study of aging (CCBPstudy. com), designed to match people with neurodegenerative disorders to available therapies from which they are most biologically suitable to benefit, regardless of their clinical diagnoses.

Semantics

Original Article